Register Cart 0

Generic placeholder image

Current Medicinal Chemistry - Central Nervous System Agents

Editor-in-Chief

ISSN (Print): 1568-0150
ISSN (Online): 1875-6158

Back Subscribe

Introduction: Strategies, Molecular Targets and Animal Models Useful for Developing Therapies for Alzheimers Disease

Author(s): H. Uri Saragovi

Volume 5, Issue 1, 2005

Page: [1 - 3] Pages: 3

DOI: 10.2174/1568015053202778

Price: $65

Abstract

Next »

Rights & Permissions Print Cite

Article Metrics

13

Related Articles

The NMDA Receptor as a Therapeutic Target in Major Depressive Disorder
CNS & Neurological Disorders - Drug Targets

Synthesis and Biological Interest of Structured Docosahexaenoic Acid–Containing Triacylglycerols and Phospholipids
Current Organic Chemistry

Heme Oxygenase-2 Protects Against Glutathione Depletion-induced Neuronal Apoptosis Mediated by Bilirubin and Cyclic GMP
Current Neurovascular Research

Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases
Current Medicinal Chemistry

Every Cloud Has a Silver Lining: Proneurogenic Effects of Aβ Oligomers and HMGB-1 via Activation of the RAGE-NF-κB Axis
CNS & Neurological Disorders - Drug Targets

Ethanolamine: A Potential Promoiety with Additional Effects on the Brain
CNS & Neurological Disorders - Drug Targets

Basic Approaches in Therapy of Multiple Sclerosis (MS) and Related Diseases: Current Achievement and Prospective
Central Nervous System Agents in Medicinal Chemistry

Editorial [Hot Topic: Mitochondria as a Pharmacological Target: A Clue for Efficacy and a Reason for Toxicity (Executive Guest Editor: Nadezda Apostolova)]
Current Pharmaceutical Design

Dental Stem Cell Patents
Recent Patents on DNA & Gene Sequences

Frontier View on Nanotechnological Strategies for Neuro-therapy
Current Drug Metabolism

Glial Reaction in Parkinsons Diseases: Inflammatory Activation Signaling of Glia as a Potential Therapeutic Target
Current Signal Transduction Therapy

Diffusion Tensor Imaging to Determine Effects of Antidementive Treatment on Cerebral Structural Connectivity in Alzheimer’s Disease
Current Pharmaceutical Design

Neurobiology of Sleep Disturbances in Neurodegenerative Disorders
Current Pharmaceutical Design

Thiophene Ring-opening Reactions III: One-Pot Synthesis and Antitumor Activity of 1,3,4-Thiadiazoline–Benzothiazolo[3,2-<i>b</i>]pyridazine Hybrids†
Current Organic Synthesis

In vitro Generated Mesenchymal Stem Cells: Suitable Tools to Target Insulin Dependent Diabetes Mellitus?
Current Stem Cell Research & Therapy

State of the Art Clinical Efficacy and Safety Evaluation of N-Acetylcarnosine Dipeptide Ophthalmic Prodrug. Principles for the Delivery, Self-Bioactivation, Molecular Targets and Interaction with a Highly Evolved Histidyl-Hydrazide Structure in the Treatment and Therapeutic Management of a Group of Sight-Threatening Eye Diseases
Current Clinical Pharmacology

Mood, Memory and Movement: An Age-Related Neurodegenerative Complex?
Current Aging Science

Regulation and Quantification of Cellular Mitochondrial Morphology and Content
Current Pharmaceutical Design

Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer’s Disease
Current Alzheimer Research

Fetal Programming of the Human Brain: Is there a Link with Insurgence of Neurodegenerative Disorders in Adulthood?
Current Medicinal Chemistry

© 2024 Bentham Science Publishers | Privacy Policy